Immunotherapy-Related Cystitis: Case Report and Review of the Literature

Immune checkpoint inhibitors (ICIs) including anti-cytotoxic T-lymphocyte-associated protein 4 (anti-CTLA4) and anti-programmed death cell protein 1 (anti-PD1) have extended patient survival benefit and revolutionized cancer treatment. As ICIs rely on immune regeneration to eliminate tumor cells, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Liping, Wang, Zhiqiang, Stebbing, Justin, Wang, Zibing, Peng, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336986/
https://www.ncbi.nlm.nih.gov/pubmed/34366676
http://dx.doi.org/10.2147/OTT.S321965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336986/
https://www.ncbi.nlm.nih.gov/pubmed/34366676
http://dx.doi.org/10.2147/OTT.S321965

Ejemplares similares